Question

Difficulty: MediumOrdering Imaging Studies

A 62-year-old man with a 35-pack-year smoking history is found to have an incidental 12-mm solitary, non-calcified pulmonary nodule in the right upper lobe on a routine preoperative chest radiograph. He has no previous chest imaging available in the electronic health record for comparison. Arrange the following diagnostic and interventional modalities in the most appropriate, evidence-based sequential order for the evaluation of this patient. Assume each step yields suspicious but non-definitive findings, requiring progression to the next step in the clinical algorithm.

  1. 1Computed tomography (CT) scan of the chest
  2. 2Fluorodeoxyglucose positron emission tomography (FDG-PET) scan
  3. 3Image-guided transthoracic core needle biopsy
  4. 4Surgical wedge resection

Answer

The correct sequence is: Computed tomography (CT) scan of the chest → Fluorodeoxyglucose positron emission tomography (FDG-PET) scan → Image-guided transthoracic core needle biopsy → Surgical wedge resection.
This sequence strictly follows established society guidelines for the management of a solitary pulmonary nodule greater than 8 mm, progressing logically from structural imaging to metabolic imaging, followed by minimally invasive tissue sampling, and concluding with definitive invasive surgery.

Step-by-Step Solution

1
Identify the clinical scenario and the need for further characterization of the newly discovered pulmonary nodule.
The patient has a 12-mm solitary pulmonary nodule and a significant smoking history, placing him at high risk for lung cancer.
Initial chest radiographs lack the spatial resolution necessary to evaluate nodule margins, internal characteristics, or precise size.
2
Select the initial advanced imaging modality to characterize the nodule.
A dedicated computed tomography (CT) scan of the chest is ordered.
CT is the gold standard for assessing the morphological features of a pulmonary nodule and is required to guide subsequent management.
3
Determine the next non-invasive step for a nodule > 8 mm with suspicious CT features.
A fluorodeoxyglucose positron emission tomography (FDG-PET) scan is ordered.
PET scanning assesses the metabolic activity of nodules > 8 mm, helping to differentiate benign from malignant lesions and providing initial staging information non-invasively.
4
Select the appropriate procedure for obtaining a tissue diagnosis after a suspicious PET scan.
An image-guided transthoracic core needle biopsy is performed.
Minimally invasive tissue sampling is required to confirm the histological diagnosis of malignancy before proceeding to highly invasive definitive surgery.
5
Determine the final step if the needle biopsy is non-diagnostic but clinical suspicion remains high.
Surgical wedge resection is indicated.
Surgical excision provides a definitive excisional biopsy and can be therapeutic if the lesion is an early-stage localized malignancy.

Key Concept

The evaluation of a solitary pulmonary nodule > 8 mm in a high-risk patient follows a stepwise progression: morphological characterization (CT chest), metabolic evaluation (FDG-PET), minimally invasive tissue sampling (image-guided biopsy), and finally definitive surgical excision if preceding steps fail to yield a diagnosis.
Rate this question